Is this you? Create Your Porfile
Avatar

A. du Bois

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where A. du Bois is active.

Explore More

Publication

Featured researches published by A. du Bois.

Ejc Supplements | 2004

Prospective investigation of the significance of cardiac markers, NT-pro Brain Natriuretic Peptide (NT-proBNP) and Troponin T (TnT), in the Hercules study of epirubicin/cyclophosphamide with or without trastuzumab (Herceptin®)

B Langer; Michael Muscholl; M Pauschinger; Christoph Thomssen; Holger Eidtmann; Michael Untch; H. G. Meerpohl; A. du Bois; H Weber; H.-J. Lueck

Ejc Supplements | 2003

36 Paclitaxel/Carboplatin(TC) vs Paclitaxel/Carboplatin sequentially followed by Topotecan (TC-Top) in first-line treatment of ovarian cancer Flgo stages IIB – IV interim results of a gynaecologic cancer intergroup phase III trial of the Ago ovarian cancer study group and Gineco

E. Pujade-Lauraine; J. Pfisterer; Alain Lortholary; R. Kimmig; B. Weber; A. du Bois; Hugues Bourgeois; U. Wagner; Werner Meier; S. Costa

Ejc Supplements | 2009

8030 Prospective validation of a predictive score for complete tumor resection in recurrent ovarian cancer (ROC): an intergroup study of AGO kommission OVAR, AGO-OVAR, AGO Austria, MITO and NOGGO

Jalid Sehouli; P. Harter; Alexander Reuss; Annette Hasenburg; Giovanni Scambia; David Cibula; Sven Mahner; Ignace Vergote; Alexander Reinthaller; Alexander Burges; Lars Hanker; Martin Pölcher; Christian Kurzeder; Ulrich Canzler; K. U. Petry; Andreas Obermair; Edgar Petru; Barbara Schmalfeldt; Domenica Lorusso; A. du Bois

Ejc Supplements | 2009

8057 How relevant is the CA-125 monitoring for patients with ovarian cancer in the follow-up? – Results from a multicenter survey in 1060 patients with ovarian cancer

G. Oskay-Özcelik; A. du Bois; Peter A. Fasching; Sven Mahner; C. Liebrich; A. Glab; S. Schmidt-Wetzel; C. Münstedt; W. Lichtenegger; Jalid Sehouli

Ejc Supplements | 2007

O-49 A phase III trial of Gemcitabine plus Docetaxel (GD) versus Capecitabine plus Docetaxel (CD) for patients (pt) with anthracycline-pretreated metastatic breast cancer

Stephen Chan; R. Sharma; Gilles Romieu; T. Huober; Thierry Delozier; Michèle Tubiana-Hulin; Andreas Schneeweiss; Ana Lluch; Antonio Llombart; A. du Bois; Eva Carrasco; A. Thareau; Pierre Fumoleau

Ejc Supplements | 2007

5005 ORAL Randomized, multicenter, 2-dose-level, open-label, phase IIa study with the intraperitoneally infused trifunctional bispecific antibody catumaxomab (anti-EpCAM × anti-CD3) to select the better dose level in platinum refractory epithelial ovarian cancer patients

Sibylle Loibl; J. Pfisterer; Pauline Wimberger; Christian Kurzeder; A. du Bois; Jalid Sehouli; A. Belau; N. Burchardi; Ignace Vergote; U. Wagner

Ejc Supplements | 2003

172 Phase I/II study of PLD and carboplatin in patients with advanced gynaecological carcinomas. An interim analysis of the GYN II trial of the AGO ovarian cancer study group

V. Heilmann; Alexander Burges; M. Gropp; J. Pfisterer; Barbara Schmalfeldt; B. Richter; C. Jackisch; Anne Stähle; R. Kimmig; A. du Bois

Ejc Supplements | 2003

164 Primary therapy of ovarian cancer with paclitaxel/carboplatin/gemcitabine (TCG): a phase II study (ovar-8 protocol)

A. Belau; U. Wagner; J. Pfisterer; B. Richter; Anne Stähle; C. Jackisch; H.-J. Lück; W. Schröder; S. Olbricht; A. du Bois

Ejc Supplements | 2003

38 Influence of amifostine on neuroprotection in 1st-line treatment of advanced ovarian cancer with carboplatin/taxane-based chemotherapy - a double-blind, placebo-controlled, randomized phase II-study from the AGO Ovarian Cancer Study Group

Pauline Wimberger; R. Kimmig; Felix Hilpert; Anne Stähle; Alexander Burges; O. Tomé; D. Rossner; K. Späthe; V. Heilmann; A. du Bois

Ejc Supplements | 2003

41 HER2-expression in advanced ovarian cancer: A prognostic and predictive marker? An study of the AGO ovarian study group

H.-J. Lück; Friedrich Kommoss; E. Riener; N. Arnold; Hp Adams; Felix Hilpert; A. du Bois; J. Pfisterer

Explore More

Collaboration

Dive into the A. du Bois's collaboration.

Top Co-Authors
Avatar

Anne Stähle

University of Duisburg-Essen

View shared research outputs
Top Co-Authors
Avatar

B. Richter

Hochschule Hannover

View shared research outputs
Top Co-Authors
Avatar

Jalid Sehouli

Charité

View shared research outputs
Top Co-Authors
Avatar

U. Wagner

University of Marburg

View shared research outputs
Top Co-Authors
Avatar

A. Belau

University of Greifswald

View shared research outputs
Top Co-Authors
Avatar

Barbara Schmalfeldt

University of Hamburg

View shared research outputs
Top Co-Authors
Avatar

C. Jackisch

University of Marburg

View shared research outputs
Top Co-Authors
Avatar

Christian Kurzeder

University of Ulm

View shared research outputs
Top Co-Authors
Avatar

Felix Hilpert

University of Kiel

View shared research outputs
Top Co-Authors
Avatar

Pauline Wimberger

Dresden University of Technology

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge